Literature DB >> 24117994

Achieved pregnancy with the delivery of a healthy child by TESE-ICSI 7 years after bilateral adult orchidopexy: a case report.

K Matsushita1, K Yamaguchi, F Li, K Okada, M Ando, K Chiba, M Koshida, H Miyake, M Fujisawa.   

Abstract

We report pregnancy with the delivery of a healthy child by TESE-ICSI 7 years after bilateral adult orchidopexy. A 29-year-old patient presented with infertility and previous bilateral cryptorchidism, but no surgical treatment had ever been performed. His partner had been assessed by a gynaecologist, and no contributing female factors were detected. Orchidopexy and conventional testicular sperm extraction (TESE) were performed and microdissection TESE 10 months after orchidopexy. The second microdissection TESE with intracytoplasmic sperm injection (ICSI) was performed 7 years after orchidopexy. The couple achieved pregnancy with the delivery of a healthy child by TESE-ICSI. It is concluded that bilateral orchidopexy in adulthood progresses spermatogenesis gradually, and microdissection TESE may succeed after a certain period of time following treatment.
© 2013 Blackwell Verlag GmbH.

Entities:  

Keywords:  Adult orchidopexy; repeat microdissection TESE; spermatogenesis

Mesh:

Year:  2013        PMID: 24117994     DOI: 10.1111/and.12174

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  3 in total

Review 1.  Management of non-obstructive azoospermia.

Authors:  Koji Chiba; Noritoshi Enatsu; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2016-01-18

2.  A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco-TESE.

Authors:  Kazumasa Hayashi; Teruo Inamoto; Haruhito Azuma; Hiroshi Masuda; Hirotsugu Oku
Journal:  Clin Case Rep       Date:  2020-11-23

3.  Benefits of orchidopexy on the fertility of adult men with bilateral cryptorchidism.

Authors:  Yan Zhang; Wei Huang; Zheng-Hui Hu; Min Cao; Hong-Shen Wu; Jun-Jie Cao; Fei-Fan Wang; Xiao-Dong Jin
Journal:  Asian J Androl       Date:  2018 Nov-Dec       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.